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ABSTRACT
Objective: To provide an overview of effective
interventions aimed at reducing rates of adverse events
in hospitals.
Design: Systematic review of systematic reviews.
Data sources: PubMed, CINAHL, PsycINFO, the
Cochrane Library and EMBASE were searched for
systematic reviews published until October 2015.
Study selection: English-language systematic reviews
of interventions aimed at reducing adverse events in
hospitals, including studies with an experimental
design and reporting adverse event rates, were
included. Two reviewers independently assessed each
study’s quality and extracted data on the study
population, study design, intervention characteristics
and adverse patient outcomes.
Results: Sixty systematic reviews with moderate to high
quality were included. Statistically significant pooled
effect sizes were found for 14 types of interventions,
including: (1) multicomponent interventions to prevent
delirium; (2) rapid response teams to reduce
cardiopulmonary arrest and mortality rates; (3)
pharmacist interventions to reduce adverse drug events;
(4) exercises and multicomponent interventions to
prevent falls; and (5) care bundle interventions, checklists
and reminders to reduce infections. Most (82%) of the
significant effect sizes were based on 5 or fewer primary
studies with an experimental study design.
Conclusions: The evidence for patient-safety
interventions implemented in hospitals worldwide is
weak. The findings address the need to invest in high-
quality research standards in order to identify
interventions that have a real impact on patient safety.
Interventions to prevent delirium, cardiopulmonary
arrest and mortality, adverse drug events, infections
and falls are most effective and should therefore be
prioritised by clinicians.
INTRODUCTION
Improving patient safety is an ongoing
concern for healthcare providers, managers
and policymakers. Worldwide, the prevalence
of patient harm and death as a result of
adverse events is about 10% among hospita-
lised patients. Half of these adverse events
are considered avoidable.1 Despite the
widespread implementation of interventions
to reduce patient harm, patient safety is not
improving.2–4
Substantial effort has been invested into
developing and implementing safety
improvements.5–7 Patient-safety improvement
interventions have been deﬁned as: practices,
strategies, structures, procedures, behaviour
or actions to prevent or mitigate unintended
patient harm, resulting from the healthcare
process across a range of diseases and proce-
dures.8–11 Several reviews have studied the
nature and effectiveness of a broad range of
these patient-safety interventions.5 12–15
However, the ﬁndings of these reviews need
to be seen in the light of several limitations.
The reviews included studies with weak
designs, lacking a systematic approach, or
were conducted more than a decade ago.
Most importantly, none of the reviews
reviewed or prioritised patient-safety inter-
ventions based on their effects on adverse
event and mortality rates. So far, patient-
safety interventions have not been reviewed
or prioritised based on effect measures.
Strengths and limitations of this study
▪ This review offers a unique overview of effective
patient-safety interventions based on data from
systematic reviews, thereby producing a stronger
evidence-based oversight of effective interven-
tions compared to the outcomes of a systematic
review of primary studies.
▪ For several patient-safety interventions that are
implemented worldwide, there is a lack of high-
quality studies in which these interventions are
evaluated.
▪ The found estimates of effectiveness of patient-
safety interventions might vary across contexts,
such as small versus large hospitals, academic-
ally affiliated hospitals versus those that are not
and the availability of factors that stimulate suc-
cessful implementation of interventions.
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Better insight into the effectiveness of interventions
aimed to reduce adverse events and preventable deaths
within hospitals is needed to assist managers and health-
care providers with deliberately selecting patient-safety
interventions based on available evidence16 and to dis-
seminate effective patient-safety improvement interven-
tions into routine practice.3 Therefore, the aim of this
study was to systematically review systematic reviews of
interventions aimed at improving patient safety in hospi-
tals by evaluating interventions, the studies they were
tested in and the effect sizes found.
METHODS
We conducted this systematic review with a prespeciﬁed
protocol (see online supplementary appendix 1), in
accordance with the preferred reporting items for sys-
tematic reviews and meta-analyses (PRISMA) and the
AMSTAR (A MeaSurement Tool to Assess systematic
Reviews) checklist for systematic reviews (see online
supplementary appendices 2 and 3).17 18
Data sources and searches
We searched for systematic reviews from inception to 22
July 2013, using the following scientiﬁc databases:
PubMed (including MEDLINE), CINAHL, PsycINFO,
the Cochrane Library and EMBASE. We used the ﬁlters
for searching papers on patient safety developed by
Tanon et al19 to maximise the sensitivity of our literature
search. The search terms used are described in detail in
online supplementary appendix 4. We updated the
search until 6 October 2015 (see ﬂow chart in ﬁgure 1).
Additional hand searches were conducted in high-impact
journals and online databases in the ﬁeld of patient safety,
from April 2010 to May 2015, including: Systematic Reviews
Journal, Annals of Internal Medicine, BMJ, BMJ Quality and
Safety in Healthcare and the International Journal of Quality in
Healthcare. Finally, references from the included systematic
reviews and bibliographies of published and unpublished
reviews related to our study objective were scanned to iden-
tify eligible systematic reviews.
Systematic review selection
Two researchers (MZ and GH) independently assessed
the inclusion eligibility of the retrieved systematic reviews
according to a standardised format (see online
supplementary appendix 1). The initial selection for
inclusion was based on the title and abstract of the system-
atic reviews. A full-text copy of the article was retrieved
and reviewed, in case the title and abstract provided insuf-
ﬁcient information to determine its relevance. For the
ﬁnal selection, a full-text copy of the systematic reviews
was examined to determine whether it fulﬁlled the inclu-
sion criteria. Disagreement about inclusion was solved by
discussion. When no consensus could be achieved, a
third reviewer (HW) made the ﬁnal decision.
Each systematic review had to meet the following criteria
(see online supplementary appendix 1):
1. English-language, full-text published and unpub-
lished systematic reviews;
2. including any study matching the Cochrane Effective
Practice and Organisation of Care (EPOC) criteria
for study designs, including: randomised controlled
trials, non-randomised controlled trials, controlled
before–after studies and interrupted time series;20
3. focusing on population of hospitalised patients across
a range of diseases and procedures;
4. regarding patient-safety interventions (aimed at chan-
ging healthcare processes, structures, strategies, behav-
iour or actions) targeted at reducing adverse events;
5. reporting quantitative effect measures.
Systematic reviews that met any of the ﬂowing criteria
were excluded from the review:
1. only obtaining observational studies;
2. only obtaining pharmacological studies;
3. only obtaining psychiatric, obstetric patients or neo-
nates as the study population/sample;
4. only including process errors or consequences of
adverse events (eg, readmission and length of stay).
Systematic reviews were included if they included
observational studies and studies that met the EPOC cri-
teria. Of these systematic reviews, only the studies that
met the EPOC criteria for study designs were studied
and were called ‘eligible studies’.
Data extraction and quality assessment
One researcher (WG) extracted the data from the
included systematic reviews, using a standardised form
(see online supplementary appendix 1). The extracted
data were checked by a second researcher (GH).
Disagreement was resolved through discussion, and a
third person (MZ) was consulted if needed. We limited
the data extraction to the prespeciﬁed elements, includ-
ing the intervention components, design and number of
included studies, study sample (nature and size) and
effect measures. Of all of the studies in a systematic
review, only data from studies that met our selection cri-
teria (called ‘eligible studies’) were extracted and
analysed.
Three reviewers (MZ, GH and WG) independently
assessed the extent to which the systematic review was
conducted to the highest possible standards, using a
quality assessment form (see online supplementary
appendix 1) that included the 11 AMSTAR quality cri-
teria.18 Systematic reviews scored 1 point for each ful-
ﬁlled criterion, and a total score for each systematic
review was calculated. A score of 0–3 was classiﬁed as
‘low’, 4–7 as ‘moderate’ and 8–11 as ‘high’.21
Data synthesis and analysis
The study characteristics and patient outcomes for all of
the systematic reviews that met our inclusion criteria
were organised in a tabular form. The systematic reviews
included were classiﬁed into patient-safety areas. The
classiﬁcation was adapted from previous reviews on
patient-safety interventions.11 12 14
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The overlap in primary studies between systematic
reviews was studied. Systematic reviews of which all
included studies were included in a more recent system-
atic review (100% overlap) were excluded. We reported
the proportion (%) overlap between included systematic
reviews per patient-safety area.
We compiled the pooled effect sizes of meta-analyses
reported in the systematic reviews and analysed the inter-
vention components. Subsequently, we ranked the effect-
ive interventions based on their effect size.
RESULTS
Search results
Our initial search identiﬁed 11 032 records (ﬁgure 1).
The title and abstract scan resulted in 172 articles that
underwent full-text review. Thirty-six articles met our
selection criteria after the full-text review. The exclusion
reasons for the 136 articles are given in online
supplementary appendix 5. Four additional articles were
identiﬁed through hand searching and snowballing, and
20 additional articles were identiﬁed through an update
of our search action. The ﬁnal set consisted of 60 arti-
cles22–81 that underwent data abstraction and analysis.
Methodological quality
Four (6.7%) systematic reviews scored low, 30 (50.0%)
scored moderate and 26 (43.3%) scored high on meth-
odological quality. Their AMSTAR scores ranged from 2
to 10 (see online supplementary appendix 6), with a
mean score of 6.9 (SD ±2.2). None of the included sys-
tematic reviews fulﬁlled all of the AMSTAR criteria.
Online supplementary appendix 7 shows the proportion
of studies satisfying each of the 11 AMSTAR quality cri-
teria. Most (>80%) of the included systematic reviews
carried out a comprehensive literature search, reported
Figure 1 Summary of evidence search and selection. *See online supplementary appendix 5 for the exclusion reason per
systematic review after full-text selection.
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the characteristics of the included studies, assessed the
scientiﬁc quality of the included studies and used the
scientiﬁc quality of the included studies appropriately in
formulating conclusions. One-third of the systematic
reviews referred to a study protocol in which the
research questions and inclusion criteria were estab-
lished before the study was conducted, and provided a
list of included and excluded studies. None of the sys-
tematic reviews reported the conﬂicts of interest of the
included studies (see online supplementary appendix
7). Six systematic reviews (10.0%) did not include a
statement on the presence or absence of potential con-
ﬂicting sources of support for carrying out the systematic
review.42 45 46 52 68 78
Characteristics of the included systematic reviews
The characteristics of the included systematic reviews are
summarised in online supplementary appendix 8. More
than half (56.7%) of the systematic reviews were pub-
lished between 2013 and 2015. The total number of
included studies ranged from 267 81 to 138;65 the number
of eligible studies (ie, met the inclusion criteria) ranged
from 167 80 81 to 33.29 The number of participants in the
eligible studies ranged from 93875 to 225 68671 and was
not reported or unknown in 26 (43.3%) reviews.
The included reviews covered 14 patient-safety areas
(table 1). Most of the reviews were about preventing
adverse drug events (n=15), followed by infection pre-
vention (n=8), delirium prevention (n=7) and adverse
events after hospital discharge or clinical handover
(n=7).
There was overlap in the included studies between sys-
tematic reviews within speciﬁc patient-safety areas (see
online supplementary appendix 9). The overlap ranges
from 25%45 to 86%47 for ‘delirium prevention’ and
from 66%62 to 75%59 60 for ‘fall prevention’.
Effects of patient-safety interventions
The results of all included systematic reviews are sum-
marised in online supplementary appendix 10. A
meta-analysis was carried out in 30 of the 60 (50.0%) sys-
tematic reviews (table 2). The authors addressed the fol-
lowing reasons for not performing a meta-analysis: too
few studies identiﬁed (n=5); the heterogeneity of the
respective study designs (n=9), interventions (n=8),
subject groups (n=5) and reported outcomes (n=5); and
methodological limitations (eg, lack of available valid
data) of the included studies (n=5).
Seventeen meta-analyses showed a statistically signiﬁ-
cant effect on adverse drug events,36 catheter-
associated urinary tract infection (CAUTI) rates,40
central-line-associated bloodstream infection (CLABSI)
rates,39 delirium incidence,47 50 51 fall rates,61 surgical-site
infections,66 incidence of cardiopulmonary arrest,69 71
complications66 79 and mortality rates.33 41 58 66 71 75 76
Patient-safety interventions with statistically signiﬁcant
effect sizes are discussed below.
Adverse drug event
Of the 15 included systematic reviews about adverse drug
events, 2 reported statistically signiﬁcant results. Davey
et al33 found that interventions aimed at increasing anti-
biotic guideline compliance for pneumonia were asso-
ciated with a signiﬁcant reduction in mortality: risk ratio
(RR) 0.89 (95% CI 0.82 to 0.97; p=0.01). This found effect
was based on four studies. Effective intervention compo-
nents were formal presentations, academic detailing,
letters, frequent reminders by pharmaceutical representa-
tives, preprinted outpatient and admission order sheets
and reporting of outcome data to providers.
Wang et al36 found that participation of a pharmacist
in physician rounds and timely information exchange
and advice of physicians by the pharmacist (ie, on drug
interactions, appropriate dosages, dose intervals and
routes of administration) was associated with a statistic-
ally signiﬁcant reduced adverse-drug-event rate: OR 0.23
(CI 0.11 to 0.48; p<0.01). The found effect was based on
three studies, of which two complied with the Cochrane
EPOC inclusion criteria for study designs.
Infection
Three systematic reviews reported statistically signiﬁcant
effects on the reduction of infection and mortality rates
as a result of implementing interventions and care
bundles.39–41 The meta-analysis performed by Blot et al39
showed a reduction in the CLABSI rate (OR 0.39
(CI 0.33 to 0.46; p<0.01)) and reduction in the CLABSI
rate at 3 months post intervention (OR 0.30 (CI 0.10 to
0.88; p=0.028)) as a result of care bundles and check-
lists.39 These found effects were based on 41 and 6
studies, respectively, of which 5 and 4 studies met our
inclusion criteria, respectively.
Meddings et al40 reported that the use of a reminder
and/or stop order to prompt removal of unnecessary
urinary catheters led to a 53% reduction of CAUTI epi-
sodes per 1000 catheter days: rate ratio (RaR) 0.47 (CI
0.30 to 0.64; p<0.01). This meta-analysis was based on 11
studies, of which only 1 study complied with the inclu-
sion criteria for study designs.
The implementation of a programme to improve com-
pliance to sepsis care bundles led to a statistically signiﬁ-
cant decreased mortality rate: OR 0.66 (CI 0.61 to 0.72;
p<0.01). This rate is based on 48 studies, of which 3 ful-
ﬁlled the criteria for study designs.41
Delirium
Three systematic reviews reported a statistically signiﬁ-
cant reduction in delirium incidence.47 50 51 There was a
16% overlap (3 of the 19 studies) between these system-
atic reviews (see online supplementary appendix 9).
Hempenius et al47 pooled the effects of ﬁve studies
and found a statistically signiﬁcant effect of multicompo-
nent interventions to prevent delirium: OR 0.58 (CI 0.38
to 0.92). Components were education, systematic cogni-
tive screening, geriatric consultative services, supportive
psychotherapy and a scheduled pain protocol.
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Table 1 Identified systematic reviews (n=60) classified by patient-safety area (n=14)
Patient-safety area
Number of
systematic reviews
(references)
Intervention components relevant to patient safety
(effective components are in bold)
Adverse
drug event
Subarea
CPOE system 222 23 CPOE system
Medication review 424–27 Medication reconciliation
Computer-assisted decision
support/alerts
328–30 Computerised advice or decision support;
computerised drug-laboratory alerts for clinicians on
prescribing or monitoring decisions
Multicomponent
interventions
631–36 Multicomponent interventions, including
pharmacist involvement and support of care
teams or physicians; guideline implementation,
including academic detailing, reminders and
feedback of data; multicomponent intervention,
including CPOE system, changes in work schedules,
education, support systems for clinical
decision-making
Infection* Device-related infections
(CAUTI; CLABSI; VAP)
437–40 Care bundles and checklists; empowerment to stop
procedure; surveillance; infrastructure and
organisational changes; training on appropriate
catheter placement; catheter restriction and
removal protocols; reminder or stop order to
decrease catheter placement; use of specific
technologies
Sepsis 141 Multicomponent programme aimed at improving
compliance to sepsis care bundles, including
education and decision support tools
Hand-hygiene compliance 242 43 Education; audit and feedback; health promotion;
variations in the availability and type of products used
for hand hygiene
Overall hospital-acquired
infection
144 Education; protocols to remove catheters
Delirium 745–51 Psychiatric assessment; special care; daily visits by a
liaison nurse; interdisciplinary team; supportive
psychotherapy; multicomponent intervention,
including cognitive screening, proactive geriatric
consultation and psychotherapy; multicomponent
intervention, including early mobility, cognition
and orientation, sleep–wake cycle preservation;
multicomponent intervention, including
physiotherapy, family involvement and staff/
family-member education
Adverse event after hospital discharge or
clinical handover
752–58 Postacute intermediate care units; geriatric
assessment; liaison nurse; predischarge assessment
of risks; patient engagement; individualised patient
record; multidisciplinary discharge planning team;
clinical follow-up; nurse-led early-discharge
planning programmes
Fall 459–62 Addressing risk factors by a multidisciplinary
team; care planning; environmental changes;
movement alarms; physiotherapy; management of
urinary incontinence; multicomponent interventions,
including risk alert card, exercise, education, hip
protectors and geriatric assessment
Adverse event in surgery 563–67 Screening and decolonisation of surgical-site
infections; subspecialisation; benchmarking;
technology or training; surgical safety checklist
Cardiopulmonary arrest 468–71 Critical-care outreach service; rapid response
teams
Continued
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Hshieh et al50 reviewed studies evaluating non-
pharmacological interventions, including the following
components: early mobility, cognition and orientation,
sleep–wake cycle preservation, hydration, hearing and
vision. They found a statistically signiﬁcant reduction in
delirium incidence: OR 0.47 (CI 0.38 to 0.58); p<0.01.
This rate was based on 11 studies, of which 7 complied
with the inclusion criteria for study designs.
Martinez et al51 found a statistically signiﬁcant reduc-
tion in delirium incidence: RR 0.73 (CI 0.63 to 0.85);
p<0.01. This rate was based on seven studies, using dif-
ferent multicomponent interventions, but a number of
speciﬁc components were shared: physiotherapy, daily
reorientation, family involvement in care, stimulation
programmes with avoidance of sensorial deprivation and
staff/family-member education.
Adverse event after hospital discharge or clinical handover
Six systematic reviews pooled the effect of interventions
to improve clinical handover or hospital discharge. One
systematic review reported a statistically signiﬁcant effect
size: nurse-led early-discharge planning programmes
were associated with a lower mortality rate: RR 0.70 (CI
0.52 to 0.95; p=0.02).58 This found effect was based on
ﬁve studies. Effective intervention components were an
individual discharge plan to address identiﬁed transi-
tional care needs, comprehensive discharge plan and
home-based follow-up visits or telephone calls by provi-
ders to patients after their hospital discharge.
Fall
One systematic review61 reported the effectiveness of
fall-prevention interventions. Additional physiotherapy
reduced the risk of falling: RR 0.36 (CI 0.14 to 0.93).
Multicomponent interventions reduced the fall rate: RaR
0.69 (CI 0.49 to 0.96). These rates were based on two and
four studies, respectively. Effective components of the multi-
factorial interventions were fall-risk alert card and informa-
tion brochure, exercise programme, education programme,
hip protectors, comprehensive geriatric assessment and
treatment of fall-risk factors by a multidisciplinary team.
Surgical adverse event
The implementation of a surgical checklist was asso-
ciated with a reduction of complications, deaths and
surgical-site infections: RR 0.59 (CI 0.47 to 0.74), 0.77
(CI 0.60 to 0.98) and 0.57 (CI 0.41 to 0.79), respectively.
These pooled rates were based on ﬁve studies.66 The
authors reported that the results were statistically signiﬁ-
cant but cannot be regarded as deﬁnitive in the absence
of high-quality studies.66
Cardiopulmonary arrest
Two systematic reviews found an association between the
implementation of a rapid response team and improved
Table 1 Continued
Patient-safety area
Number of
systematic reviews
(references)
Intervention components relevant to patient safety
(effective components are in bold)
Venous thromboembolism 272 73 Alerts and education; real-time audit and feedback;
multicomponent interventions to improve appropriate
administration of thromboprophylaxis
Staffing 374–76 Increasing proportion of support staff; addition of
specialist nursing post to staffing; reducing shift
length; protected sleep time; night float; education
among residents; interdisciplinary team
interventions
Pressure ulcer 177 Standardisation of interventions; multidisciplinary
teams and leadership; designated skin champions;
education; audit and feedback
Mechanical complication and underfeeding 178 Total parenteral nutrition team: nutrition support for
patients who are unable to obtain adequate nutrition
either via the oral or enteral route
Clinical pathway 179 Clinical pathways: multidisciplinary care plans with
essential steps in care, supporting the translation of
clinical guidelines into local protocols and application
in practice
Safety culture 180 Error-prevention training; restructured patient-safety
governance; lessons-learnt programme; cause
analysis programme; executive rounds
External inspection 181 External inspections of compliance with standards
(eg, accreditation)
*Surgical-site infections were classified as ‘prevention of adverse events in surgery’.
CAUTI, catheter-associated urinary tract infection; CLABSI, central-line-associated bloodstream infection; CPOE, computerised physician
order entry; VAP, ventilator-associated pneumonia.
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Table 2 Effect sizes of patient-safety interventions: results from meta-analyses (n=30) reported in the 60 included systematic reviews
Patient-safety area
Reference
meta-analysis Intervention Patient outcome
Effect size (95% CI)
significant effect sizes
are bold
p
Value
Studies in
meta-analysis (n)
(eligible studies* (n))
Adverse drug event
Medication review
Holland et al24 Pharmacist-led medication review Mortality RR 0.96 (0.82 to 1.13) 0.62 22
Christensen and
Lundh26
Medication review Mortality RR 0.98 (0.78 to 1.23) 0.86 4
Hohl et al27 Medication review Mortality OR 1.09 (0.69 to 1.72) 0.71 3
Adverse drug event
Computerised advice on
drug dosage
Durieux et al28 Computerised advice on drug dosage Mortality RR 0.81 (0.37 to 1.81) 0.61 6
Gillaizeau et al29 Computerised advice on drug dosage Mortality RR 1.08 (0.80 to 1.45) 0.61 10
Bayoumi et al30 Computerised drug-laboratory alerts Adverse events
(bleeding and
thrombosis)
OR 0.88 (0.78 to 1.00) 0.05 4
Adverse drug event
Multicomponent
interventions
Davey et al33 Intervention for antimicrobial therapy Mortality RR 0.92 (0.69 to 1.22) 0.56 3
Antibiotic guideline for pneumonia Mortality RR 0.89 (0.82 to 0.97) 0.01 4
Decrease excessive prescribing Mortality RR 0.92 (0.81 to 1.06) 0.25 11
Wang et al36 Pharmacist interventions Preventable adverse
drug events
OR 0.23 (0.11 to 0.48) <0.01 3 (2)
Infections Blot et al39 Care bundle/checklist interventions CLABSI OR 0.39 (0.33 to 0.46) <0.01 41 (5)
CLABSI rate at 3 months OR 0.30 (0.10 to 0.88) 0.03 6 (4)
Meddings et al40 Catheter reminder and stop order CAUTI episodes per
1000 catheter days
RR 0.47 (0.30 to 0.64) <0.01 11 (1)
CAUTI RR 0.72 (0.52 to 0.99) 0.05 8 (2)
Damiani et al41 Sepsis bundle Mortality OR 0.66 (0.61 to 0.72) <0.01 48 (3)
Delirium Hempenius
et al47
Multicomponent interventions, including
cognitive screening, proactive geriatric
consultation and psychotherapy
Incidence of delirium OR 0.58 (0.38 to 0.92) NR 5
One-component interventions Incidence of delirium OR 1.05 (0.09 to 11.57) NR 2
Hshieh et al50 Multicomponent intervention, including
early mobility, cognition and orientation
Incidence of delirium OR 0.47 (0.38 to 0.58) <0.01 11 (7)
Martinez et al51 Multicomponent intervention, including
physiotherapy, daily reorientation, family
involvement and staff/family-member
education
Incidence of delirium RR 0.73 (0.63 to 0.85) <0.01 7
Adverse event after
hospital discharge or
clinical handover
Griffiths et al52 Nursing-led inpatients units Mortality OR 1.10 (0.56 to 2.16) 0.64 7
Mortality 3 or 6 months
post admission
OR 0.96 (0.63 to 1.47) 0.62 6
Conroy et al53 Comprehensive geriatric assessment Mortality RR 0.92 (0.55 to 1.52) 0.77 5
Niven et al54 Critical-care transition programmes Mortality RR 0.84 (0.66 to 1.05) 0.1 3 (2)
Shepperd et al56 Discharge planning from hospital to
home
Mortality at 6–9 months RR 1.00 (0.79 to 1.26) 0.69 6
Falls RR 0.87 (0.50 to 1.49) 0.61 1
Lowthian et al57 Optimised ED discharge Mortality up to
18 months postdischarge
OR 1.01 (0.70 to 1.47) 0.94 2
Zhu et al58 Nurse-led early-discharge planning Mortality RR 0.70 (0.52 to 0.95) 0.02 5
Continued
Zegers
M
,etal.BM
J
Open
2016;6:e012555.doi:10.1136/bm
jopen-2016-012555
7
O
p
e
n
A
c
c
e
s
s
group.bmj.com
 o
n
 M
ay 30, 2017 - Published by 
http://bmjopen.bmj.com/
D
ow
nloaded from
 
Table 2 Continued
Patient-safety area
Reference
meta-analysis Intervention Patient outcome
Effect size (95% CI)
significant effect sizes
are bold
p
Value
Studies in
meta-analysis (n)
(eligible studies* (n))
Fall Oliver et al59 Multicomponent intervention Falls RaR 0.82 (0.68 to 1.00) NR 12
Fallers RR 0.95 (0.71 to 1.27) NR 12
Fractures RaR 0.59 (0.22 to 1.58) NR 12
Coussement
et al60
Multicomponent intervention Falls RR 0.82 (0.65 to 1.03) NR 4
Number of fallers RR 0.87 (0.70 to 1.08) NR 4
Cameron et al61 Multicomponent interventions Rate of falls RaR 0.69 (0.49 to 0.96) 0.03 4
Risk of falling RR 0.71 (0.46 to 1.09) 0.12 3
Exercises Risk of falling RR 0.36 (0.14 to 0.93) 0.04 2
Adverse event in surgery Bergs et al66 WHO surgical safety checklist Any complication RR 0.59 (0.47 to 0.74) <0.01 5
Mortality RR 0.77 (0.60 to 0.98) 0.04 4 (3)
Surgical-site infections RR 0.57 (0.41 to 0.79) <0.01 5
Cardiopulmonary arrest Chan et al69 Rapid response team Mortality RR 0.92 (0.82 to 1.04) NR 16
Cardiopulmonary arrest RR 0.65 (0.55 to 0.77) NR 16
Maharaj et al71 Rapid response team Mortality RR 0.91 (0.85 to 0.97) <0.01 4
Cardiopulmonary arrest RR 0.74 (0.56 to 0.98) 0.04 2
Venous thromboembolism Kahn et al72 Alerts All venous
thromboembolism
RR 0.85 (0.49 to 1.46) NR 3
Multicomponent interventions All venous
thromboembolism
RR 1.01 (0.51 to 1.98) NR 5
Symptomatic deep vein
thromboembolism
RR 0.59 (0.18 to 1.98) NR 3
Staffing Butler et al75 Addition of specialist nursing post to
staffing
In-hospital mortality RR 0.96 (0.59 to 1.56) 0.86 1
Postdischarge adverse
events
RR 1.03 (0.70 to 1.53) 0.87 1
Increasing the proportion of support
staff
Mortality in trauma unit RR 0.41 (0.16 to 1.01)) 0.05 1
Mortality in hospital RR 0.56 (0.29 to 1.09) 0.09 1
Mortality at 4 months RR 0.57 (0.34 to 0.95) 0.03 1
Pannick et al76 Interdisciplinary teams Mortality wRR 0.92 (0.82 to 1.05) NR 7
Team practice interventions Mortality wRR 0.67 (0.45 to 0.99) NR 2
Clinical pathway Rotter et al79 Clinical pathway Mortality OR 0.84 (0.64 to 1.11) 0.23 3
Complications up to
3 months
OR 0.31 (0.13 to 0.72) 0.07 1
In-hospital complications OR 0.58 (0.36 to 0.94) 0.03 5
*Study design in accordance with methodological criteria of the Cochrane EPOC review group and quantitative data on adverse event rates were reported.
CAUTI, catheter-associated urinary tract infection; CLABSI, central-line-associated bloodstream infection; EPOC, Effective Practice and Organisation of Care; NR, not reported; RaR, rate ratio;
RR, risk/relative ratio; wRR, weighted risk ratio.
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patient outcomes. There is an 11% overlap (2 of the 19
studies) between these systematic reviews (see online
supplementary appendix 9). Chan et al69 performed a
meta-analysis on 16 studies and found a statistically sig-
niﬁcant reduction of cardiopulmonary arrests outside
the intensive care unit, following the implementation of
the rapid response team: RR 0.65 (CI 0.55 to 0.77). The
authors of the systematic review raised questions about
the effectiveness of rapid response team implementation
given the lack of an effect of rapid response teams on
mortality.
The systematic review of Maharaj et al71 found a statis-
tically signiﬁcant reduction in cardiopulmonary arrests
based on two studies: RR 0.74 (CI 0.56 to 0.98; p=0.04)
and a statistically signiﬁcant reduction of deaths based
on four studies: RR 0.91 (CI 0.85 to 0.97; p<0.01).
Staffing
Butler et al75 found 6202 studies that were potentially
relevant to studying the effect of hospital-nurse stafﬁng
models on mortality and adverse events. However, one
study reported a statistically signiﬁcant effect: increasing
the proportion of support staff (ie, dietetic assistants)
reduced mortality at 4 months: RR 0.57 (CI 0.34 to 0.95;
p=0.03). The authors stated that they were unable to
draw conclusions because of the small number of eli-
gible studies.
Pannick et al76 found that interdisciplinary team inter-
ventions reduced mortality rates: RR 0.67 (CI 0.45 to
0.99). The ﬁnding was based on two studies. Effective
intervention components were interdisciplinary rounds,
including physician, nurse, pharmacist, nutritionist and
social worker; expanded senior clinical nurse roles;
incorporating structured detailed assessments of premor-
bid functional and social patient data and investment in
allied health professionals as consistent staff members.
Clinical pathway
Rotter et al79 found an association between the use of clin-
ical pathways and a reduction of in-hospital complications,
based on ﬁve studies: OR 0.58 (CI 0.36 to 0.94). Examples
of reported complications were postoperative confusion,
infection, uncontrolled bleeding and deep vein throm-
bosis, ventilator-associated pneumonia, joint dislocation
and decreased postdischarge mobility up to 3 months post-
surgery. The OR for complications up to 3 months, based
on one study, was 0.31 (CI 0.13 to 0.72).
Summary of effective patient-safety interventions
Patient-safety interventions that result in a signiﬁcant
reduction in adverse event or mortality rates are pre-
sented in table 3.
Exercises to reduce the risk of falling, surgical safety
checklist to reduce the rate of surgical-site infection, rapid
response team to prevent cardiopulmonary arrest and mul-
ticomponent interventions to prevent delirium have signiﬁ-
cantly better results compared to changes in stafﬁng and
interventions to improve hospital discharge to prevent
mortality. Pharmacist interventions and care bundle inter-
ventions and checklists were signiﬁcantly associated with,
respectively, reduced rates of adverse drug events and
infection rates. These effect measures are, however, partly
based on experimental studies (table 3).
Fourteen of the 17 signiﬁcant effect sizes (82.4%)
were based on ﬁve or fewer studies that comply with the
inclusion criteria for study design. The effect measures
were based on sample sizes varying from 83 to 1 143 495
patients, for exercises to reduce the risk of falling and
rapid response team to reduce the rate of cardiopul-
monary arrest, respectively (table 3). The AMSTAR
scores of the systematic reviews of the 17 effective
patient-safety interventions ranged from 4 to 10, with a
mean score of 7.5 (SD ±1.9).
Three systematic reviews evaluated multicomponent
interventions to prevent delirium (all with different com-
positions of the multicomponent intervention and dif-
ferent effect measures); two systematic reviews evaluated
the effects of rapid response teams, resulting in 14
unique patient interventions (box 1).
DISCUSSION
We systematically reviewed the literature for effective
interventions aimed at reducing adverse event rates and
preventable deaths in hospitals. The results showed that
there were 14 effective patient-safety interventions
(box 1), including: multicomponent interventions to
prevent delirium; rapid response teams to reduce cardio-
pulmonary arrest and mortality rates; exercises and mul-
ticomponent interventions to reduce the risk of falling
and surgical safety checklist to reduce the rate of
surgical-site infection. Other effective interventions were
pharmacist interventions to reduce adverse drug events,
care bundles and checklists to reduce infection and mor-
tality rates, changes in stafﬁng and interventions to
improve hospital discharge to reduce mortality rates.
The evidence base that supports the interventions is
moderate because 82% of the found effect measures
were based on ﬁve or fewer primary studies that fulﬁlled
the Cochrane EPOC criteria for study designs.20
This review offers a unique overview of effective
patient-safety interventions based on data that are
synthesised from systematic reviews, thereby producing a
stronger evidence-based oversight of effective interven-
tions compared to the outcomes of a systematic review
of primary studies.16 The overlap of primary studies in
existing reviews is analysed to minimise the potential
effects of ‘double-counting’ primary studies in multiple
reviews.82 Moreover, most of the systematic reviews
included in our review were of high methodological
quality (mean AMSTAR score of 6.9 for all included
reviews and 7.5 for the reviews with positively pooled
outcome effects), thereby increasing the credibility and
validity of our ﬁndings.18
Despite the growing number of experimental studies
evaluating the effectiveness of patient-safety interven-
tions, our ﬁndings show that the evidence base for
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Table 3 Effective patient-safety interventions (n=14*)
Intervention effect estimates based on
meta-analysis with only eligible studies† Patient outcome Effect size (95% CI) Sample size (n patients)
Study size
(n studies)
Designs of studies
(n)
Exercises61 Risk of falling RR 0.36 (0.14 to 0.93) 83 2 RCT (2)
Surgical safety checklist66 Surgical-site
infections
RR 0.57 (0.41 to 0.79) 15 198 5 ITS (5)
Increasing the proportion of support staff75 Mortality at 4 months RR 0.57 (0.34 to 0.95) 302 1 RCT (1)
Rapid response team69 Cardiopulmonary
arrest
RR 0.65 (0.55 to 0.77) 1 143 495 16 Non-RCT (2); CBA
(12); ITS (2)
Nurse-led early-discharge planning
programmes58
Mortality RR 0.70 (0.52 to 0.95) 2503 5 RCT (5)
Multicomponent interventions, including
physiotherapy, daily reorientation, family
involvement and staff/family-member
education51
Delirium RR 0.73 (0.63 to 0.85) 1691 7 RCT (7)
Antibiotic guideline for pneumonia33 Mortality RR 0.89 (0.82 to 0.97) 22 526 4 RCT (1); CBA (3)
Rapid response team71 Mortality RR 0.91 (0.85 to 0.97) 209 639 4 RCT (2); CBA (1);
ITS (1)
Interdisciplinary team interventions76 Mortality wRR 0.67 (0.45 to 0.99) 2640 2 Non-RCT (2)
Multicomponent interventions61 Falls RaR 0.69 (0.49 to 0.96) 6478 4 RCT (4)
Multicomponent interventions, including
cognitive screening, proactive geriatric
consultation and psychotherapy47
Delirium OR 0.58 (0.38 to 0.92) 1343 5 Non-RCT (3); CBA
(2)
Clinical pathway79 In-hospital
complications
OR 0.58 (0.36 to 0.94) 664 5 RCT (4); CCT (1)
Intervention effect estimates based on
meta-analysis with eligible and
non-eligible studies Patient outcome Effect size (95%CI)
Sample size (n eligible
patients) and proportion of
eligible patients of all
patients (%)
Study size (n) and
proportion of eligible
studies (n; %)
Designs of eligible
studies (n)
Catheter reminder and stop order40 Infections (CAUTI) RR 0.72 (0.52 to 0.99) U 8 (2; 25) RCT (1); non-RCT
(1)
Pharmacist interventions36 Adverse drug events OR 0.23 (0.11 to 0.48) 2794 (30.4) 3 (2; 66.7) CBA (2)
Care bundle and checklist39 Infections (CLABSI) OR 0.39 (0.33 to 0.46) 70 358 (2.8) 41 (5; 12.2) BA (36); ITS (5)
Multicomponent interventions, including
early mobility, cognition and orientation50
Delirium OR 0.47 (0.38 to 0.58) 2914 (68.3) 11 (7; 63.6) RCT (3); non-RCT
(4)
Sepsis bundle41 Mortality OR 0.66 (0.61 to 0.72) 11 720 (2.7) 48 (3; 6.3) ITS (3)
*17 systematic reviews reported about 14 types of interventions.
†Studies with a design in accordance with methodological criteria of the Cochrane EPOC review group.
CCT, controlled (clinical) trial; CAUTI, catheter-associated urinary tract infection; CBA, controlled before after; CLABSI, central-line-associated bloodstream infection; EPOC, Effective Practice
and Organisation of Care; ITS, interrupted time series; NR, not reported; RaR, rate ratio; RCT, randomised controlled trial; RR, risk/relative ratio; U, unclear; wRR, weighted risk ratio.
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patient-safety improvement is still not strong.
Furthermore, our ﬁndings are in contrast to the ﬁndings
of previous research on this topic. Shekelle et al83
strongly supported the adoption of 10 patient-safety
practices, including hand-hygiene strategies, the
do-not-use list for hazardous abbreviations and multi-
component interventions to reduce pressure ulcers. We
found limited support for the effectiveness of these
interventions while ﬁnding strong support for delirium
prevention interventions and rapid response teams. Our
review placed more emphasis on assessing interventions
on the basis of patient outcomes (ie, reduced adverse
event and mortality rates) and testing within high-quality
designs; this emphasis on the quality of studies produces
a very different assessment of which safety interventions
are most beneﬁcial for patients and which should be
implemented.
Evidence is still lacking for medication reconciliation
and several interventions to improve the safety of clinical
handover or discharge of hospitalised patients, which
are incorporated in national and international patient-
safety campaigns and are recommended by the WHO.84
However, the results of our review showed that by
looking strictly at patient outcomes and only including
high-quality studies, the evidence that these interven-
tions reduce adverse event or mortality rates remains
incomplete.
The lack of evidence for patient-safety interventions
does not mean that these interventions do not work; it
primarily addresses the lack of valid effect. Policymakers
and clinicians show good intentions by implementing
ambitious patient-safety programmes and investments of
resources. However, implementing unproven interven-
tions can lead to the opposite of what is intended with
patient-safety improvements: waste of resources, energy
and enthusiasm.85 86 In times of limited resources, we
concur with Shekelle et al and underscore previous,
urgent calls for more research on the effectiveness of
patient-safety interventions.7 12 83 85 87 88 Patient-safety
interventions should be tested on their effectiveness
based on the same high-quality standards used for drug
studies.3 89
This systematic review has several limitations. First, we
did not retrieve data from the primary studies; instead,
we used the information reported by the authors on
aspects, such as the description of the interventions and
reported outcomes. As a result, the information for
some patient-safety interventions and outcomes reported
in our systematic review is limited. However, by focusing
on the results of the systematic reviews rather than each
individual primary study, we were able to obtain a broad
overview of the ﬁeld of patient safety.90 Second, the
found estimates of effectiveness of patient-safety inter-
ventions might vary across contexts, such as small versus
large hospitals, academically afﬁliated hospitals versus
those that are not and the availability of factors that
stimulate successful implementation of interventions, for
example, strong leadership and an electronic patient
record.91 Third, in two-thirds of the included systematic
reviews, publication bias was not assessed (see online
supplementary appendix 7), meaning that the pooled
rates in these reviews may present an overestimation of
the effect size.92 Fourth, in this study, valuable narrative
syntheses from systematic reviews may have been
under-reported, because we focused on the quantitative
evidence of safety interventions. The large amount of
eligible systematic reviews and subsequent data from
primary studies restricted us to focus on the results from
meta-analyses, which are widely considered as the
highest level of evidence for the effectiveness of inter-
ventions (Oxford Centre for Evidence-Based Medicine—
Levels of Evidence). Fifth, the focus of our systematic
review was to summarise quantitative evidence for exist-
ing patient-safety interventions. A limitation of this
approach is that the found statistically signiﬁcant effect
measures may not be clinically signiﬁcant and, vice
versa, effects that are clinically relevant may not be statis-
tically signiﬁcant and were not captured in our system-
atic review.
In conclusion, patient-safety interventions are imple-
mented worldwide, even though evidence for these
interventions remains incomplete. A major cause for
this problem is the lack of high-quality studies in which
interventions are evaluated on their effects. To contrib-
ute to evidence-based patient safety, interventions need
to be evaluated based on high-quality research stan-
dards, including experimental research designs, mea-
sured outcomes at the patient level and description of
the intervention, implementation process and context in
detail. Description of these aspects is necessary to know
which factors lead to optimal effects and how to repli-
cate the patient-safety intervention in practice.93 94
Box 1 Evidence-based effective patient-safety interventions
(n=14)
Antibiotic guideline for pneumonia to reduce mortality rates.
Catheter reminder and stop order to reduce the risk for develop-
ing catheter-associated urinary tract infection.
Care bundles and checklists to reduce rates of central-line-
associated blood stream infections.
Clinical pathways to avoid complications.
Exercises to reduce the risk of falling.
Increasing the proportion of support staff to reduce mortality
rates.
Interdisciplinary team interventions to reduce mortality rates.
Multicomponent interventions to reduce the risk of falling.
Multicomponent interventions to prevent delirium.
Nurse-led early-discharge planning programmes to reduce mortal-
ity rates.
Pharmacist interventions to prevent adverse drug events.
Rapid response team to reduce the risk for cardiopulmonary
arrest and reduce mortality rates.
Sepsis bundle to reduce mortality rates.
Surgical safety checklist to reduce the risk for surgical-site infec-
tions and reduce mortality rates.
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Policymakers and clinicians should stop taking
shortcuts but need to spend more time and money con-
ducting high-quality research on the effectiveness of
patient-safety interventions to establish progress in
patient safety.
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